Area of research
Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine
Research interest
Research interests include Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Thyroid Cancer Diagnosis and Treatment, and Peptidase Inhibition and Analysis.
[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial
Head and neck squamous cell carcinoma in adults aged 45 or younger—an analysis of two tertiary cancer centres
Investigation of the CTLA-4-CD28 Axis in Oral Squamous Cell Carcinoma.
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
The Immune Checkpoint BTLA in Oral Cancer: Expression Analysis and Its Correlation to Other Immune Modulators.
Neoadjuvant Radiochemotherapy Alters the Immune and Metabolic Microenvironment in Oral Cancer-Analyses of CD68, CD163, TGF-β1, GLUT-1 and HIF-1α Expressions.
Comparative Analysis of Inhibitory and Activating Immune Checkpoints PD-1, PD-L1, CD28, and CD86 in Non-Melanoma Skin Cancer.
<sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
Advancing oral immunology for improving oral health
The Immune Checkpoint Receptor CD96: A Local and Systemic Immune Modulator in Oral Cancer?
A Treatment Approach for Carotid Blowout Syndrome and Soft Tissue Reconstruction after Radiotherapy in Patients with Oral Cancer: A Report of 2 Cases.
Postoperative Changes in Systemic Immune Tolerance Following Major Oncologic versus Minor Maxillofacial Surgery.
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities.
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study.
Beyond PD-L1-Identification of Further Potential Therapeutic Targets in Oral Cancer.
Real-Life Experience in the Treatment of Intrahepatic Cholangiocarcinoma by<sup>90</sup>Y Radioembolization: A Multicenter Retrospective Study
Performance of different osteosynthesis materials in microvascular fibula free flap reconstruction.
Time-of-Flight Angiography in Ultra-High-Field 7 T MRI for the Evaluation of Peroneal Perforator Arteries Before Osseomyocutaneous Flap Surgery
Inflammatory Response Mechanisms of the Dentine–Pulp Complex and the Periapical Tissues
Inflammatory Response Mechanisms of the Dentine-Pulp Complex and the Periapical Tissues.
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study
Initial clinical experience with <sup>90</sup>Y-FAPI-46 radioligand therapy for advanced stage solid tumors: a case series of nine patients
Tumor Sink Effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?
Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia
Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia.
Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo
Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo.